2LeeK, KimYA, JoonY et al. IncreasingprevalanceofVancomycin-ResistantEnterococci, andCefoxitin-, Imipenem-, and Fluoroquinolone-Resistant Gram-Negative Bacilli: A KONSAR study in 2002[J]. Yonsei Medical lounal, 2004,45 : 598.
3Beceiro A, Dominguez L, Ribera Aet al. Molecttlar Characterization of the Gene Encoding a new AmpC β-Laclamase in a clinical strain of Acinetobacter Genomic Species 3 ( AG3 ) [ J ]. Antimicrobial Agents and Chemotherapy,2004, p. 1374.
4Segal H, Nelson EC, Hisha BG. Genetic Environment and Transcription of ampC in an Acinetobacter baumannii Clinical Isolate[J]. Anfimicrobial Agents and Chemotherpy,2004,P.612.
5Corvec S, Caroff S, Espaze E et al. AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains[J]. Journal of Antimicrobial Chemotherapy, 2003,52: 629.
6Chen CH, Young TG, Huang CC. Predictive biomarkers for drug-resistant Acinetobacter baumannii isolates with blaTEM-1, AmpC-type bla and integrase Ⅰ genotypes,2006,39:372.
7Bou G and Jesus MB. Cloning, Nucleotide sequencing and Analysis of the Gene encoding and AmpC β-Lactamase in Acinetobacter batunanni [ J ]. Antimicrobial Agents and Chemotherapy. Feb,.2000, P:428.
8Hujer KM,Hamza NS,Hujer AM et al.ldentification of a New Variant of the Acinetobacter baumannii Cephalosporinase, ADC-7 β-Lactamase: Defining a Unique Family of Clss C Enzymes [ J ]. Antimicrobial Agents And Chemotherapy, July, 2005, p : 2941.
9Sturenburg E, Lang M, Horstkotte MA et al. Evaluation of the micrescan ESBL plus confirmation panel for detection of extended-spectrumβ-Lactarinses in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria[J]. Journal of Antimicrobial Chemotherapy,2004,54: 870.
10Yong D, Choi YS, Roh KH et al. Increasing Prevalance and Diversisty of Metallo-β-Lactamases in Psendomonas SPP, Acinetobacter SPP[J]. And Enterobactefiaceae from Koren. Antimicrobial Agents and Chemotheray, 2006, P: 1884.
